Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure,

Ai Harashima1, Yasuhiko Yamamoto, Chunmei Cheng

  • 1Department of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8640, Japan.

Insights

Researchers identified a mouse version of esRAGE (endogenous secretory RAGE), a decoy receptor. This discovery aids in understanding RAGE

Area of Science:

  • Molecular Biology
  • Immunology
  • Endocrinology

Background:

  • The receptor for advanced glycation end-products (RAGE) is implicated in diabetic vascular complications, neurodegenerative diseases, and inflammation.
  • A human splice variant, endogenous secretory RAGE (esRAGE), functions as a decoy receptor for RAGE ligands.

Purpose of the Study:

  • To isolate and characterize the murine orthologue of esRAGE.
  • To investigate the functional role and expression of murine esRAGE in vivo.

Main Methods:

  • Reverse transcription-PCR (RT-PCR) cloning from mouse brain poly(A)+ RNA.
  • Transfection experiments to confirm protein translation and function.
  • RT-PCR and immunoblotting to detect esRAGE mRNA and protein expression in various tissues.

Main Results:

  • A murine esRAGE orthologue was successfully isolated, encoding a 334-amino-acid secretory protein lacking a transmembrane domain.
  • Transfection confirmed esRAGE translation and its decoy function in inhibiting AGE-induced NF-kappaB activation.
  • esRAGE mRNA and protein were detected in multiple mouse tissues, with increased expression in the kidneys of diabetic mice.

Conclusions:

  • The study provides the first animal orthologue of esRAGE.
  • Murine esRAGE functions as a secretory decoy receptor, offering a valuable tool for studying its roles in physiological and pathological conditions, including diabetes.